Evaluation of a modified triple‐combination anesthesia using dexmedetomidine in mice
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Masaki Watanabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Towada, Japan. Hauptthemen laut MEDLINE: Dexmedetomidine, Anesthetics, Combined, Anesthesia, Hypnotics and Sedatives. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ketamine is a widely used anesthetic in animal research, but its use is strictly regulated in several countries, including Japan and China. As an alternative, the medetomidine‐midazolam‐butorphanol (MMB) combination is commonly used in Japan. However, medetomidine is a racemic mixture containing the inactive R‐enantiomer, which may reduce anesthetic predictability and safety.
Objective
The aim of the study was to evaluate the efficacy and safety of a modified anesthetic combination (dMMB), in which dexmedetomidine replaces medetomidine, across three commonly used mouse strains (ICR, C57BL/6, BALB/c).
Methods
Male and female mice were administered either MMB or dMMB subcutaneously. Anesthetic depth, recovery profiles, heart rate, SpO 2 , body temperature, ocular opacity, and blood glucose levels were assessed. Atipamezole was used to reverse anesthesia, and thermoregulatory recovery was monitored postinjection. Results dMMB produced similar anesthetic depth to MMB, with faster and more consistent recovery, particularly in males. Body temperature recovery was significantly enhanced in dMMB‐treated B6 males. No significant differences in side effects (ocular opacity or blood glucose levels) were observed between protocols, though strain‐specific glucose elevations were noted in dMMB‐treated males. Conclusion dMMB is a safe, effective, and ketamine‐free injectable anesthetic protocol, offering advantages in recovery and thermoregulation. It may be a valuable alternative in research settings where ketamine is restricted and medetomidine may become unavailable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Towada, Japan.
- Laboratory of Laboratory Animal Science, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
ORCID-Profile: Nobuya Sasaki
Zitieren
APA
Watanabe, M., Nakanishi, R., Omori, T., Sasaki, T., Asano, A., & Sasaki, N. (2025). Evaluation of a modified triple‐combination anesthesia using dexmedetomidine in mice. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70098
Vancouver
Watanabe M, Nakanishi R, Omori T, Sasaki T, Asano A, Sasaki N. Evaluation of a modified triple‐combination anesthesia using dexmedetomidine in mice. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70098
BibTeX
@article{Watanabe2025,
author = {Watanabe, Masaki and Nakanishi, Ryosuke and Omori, Tomoki and Sasaki, Takeru and Asano, Atsushi and Sasaki, Nobuya},
title = {Evaluation of a modified triple‐combination anesthesia using dexmedetomidine in mice},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.70098}
}
EUVIMED